Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Bickel

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Journal of the International AIDS Society|November 14, 2014
Proton 1H- and Phosphorus 31P-MR spectroscopy (MRS) in asymptomatic HIV-positive patientsGundolf Schuettfort, Elke Hattingen, Ulrich Pilatus, et al.
Annals of Internal Medicine|August 21, 2002
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapyOle Kirk, Peter Reiss, Caterina Uberti-Foppa, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
Comparison of drug resistance scores for tipranavir in protease inhibitor-naive patients infected with HIV-1 B and non-B subtypesMartin Stürmer, Christoph Stephan, Peter Gute, et al.
Scandinavian Journal of Infectious Diseases|July 9, 2014
Durability of protective antibody titres is not enhanced by a two-dose schedule of an ASO3-adjuvanted pandemic H1N1 influenza vaccine in adult HIV-1-infected patientsMarkus Bickel, Corinna Lais, Imke Wieters, et al.
Plos One|January 28, 2017
Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or DeathMaria Casadellà, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2021
Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT TrialPrincy Kumar, Margaret Johnson, Jean-Michel Molina, et al.
AIDS Care|March 13, 2023
Socio-demographic and psycho-social determinants of HIV late presentation in Germany - results from the FindHIV studyPaul Lauscher, Nikola Hanhoff, Frederik Valbert, et al.
Infection|September 28, 2022
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in GermanyDaniel Schmidt, Christian Kollan, Barbara Bartmeyer, et al.
Medical Microbiology and Immunology|September 18, 2012
Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapyChristoph Stephan, Valentin Bartha, Eva Herrmann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 4, 2025
Delayed CD4 cell recovery in HIV-associated disseminated non-tuberculous mycobacterial disease: a case-control studyKai Katzschner, Thomas Wichelhaus, Timo Wolf, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Journal of the International AIDS Society|November 14, 2014
Proton 1H- and Phosphorus 31P-MR spectroscopy (MRS) in asymptomatic HIV-positive patientsGundolf Schuettfort, Elke Hattingen, Ulrich Pilatus, et al.
Annals of Internal Medicine|August 21, 2002
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapyOle Kirk, Peter Reiss, Caterina Uberti-Foppa, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2011
Comparison of drug resistance scores for tipranavir in protease inhibitor-naive patients infected with HIV-1 B and non-B subtypesMartin Stürmer, Christoph Stephan, Peter Gute, et al.
Scandinavian Journal of Infectious Diseases|July 9, 2014
Durability of protective antibody titres is not enhanced by a two-dose schedule of an ASO3-adjuvanted pandemic H1N1 influenza vaccine in adult HIV-1-infected patientsMarkus Bickel, Corinna Lais, Imke Wieters, et al.
Plos One|January 28, 2017
Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or DeathMaria Casadellà, Alessandro Cozzi-Lepri, Andrew Phillips, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 26, 2021
Brief Report: Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT TrialPrincy Kumar, Margaret Johnson, Jean-Michel Molina, et al.
AIDS Care|March 13, 2023
Socio-demographic and psycho-social determinants of HIV late presentation in Germany - results from the FindHIV studyPaul Lauscher, Nikola Hanhoff, Frederik Valbert, et al.
Infection|September 28, 2022
Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in GermanyDaniel Schmidt, Christian Kollan, Barbara Bartmeyer, et al.
Medical Microbiology and Immunology|September 18, 2012
Impact of HIV-1 replication on immunological evolution during long-term dual-boosted protease inhibitor therapyChristoph Stephan, Valentin Bartha, Eva Herrmann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 4, 2025
Delayed CD4 cell recovery in HIV-associated disseminated non-tuberculous mycobacterial disease: a case-control studyKai Katzschner, Thomas Wichelhaus, Timo Wolf, et al.
Pageof 7